Benzinga | Jan 6, 2022 08:59AM EST

Cowen & Co. Initiates Coverage On Ascendis Pharma with Market Perform Rating, Announces Price Target of $136

Cowen & Co. analyst Yaron Werber initiates coverage on Ascendis Pharma (NASDAQ:ASND) with a Market Perform rating and announces Price Target of $136.